Gene therapy Flashcards

1
Q

What is the aim of gene therapy?

A

To cure genetic disease by replacing the mutated gene with a non-mutated gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does the replacement gene get to the cell?

A

Via vector sequence or lyzosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is an example of a vector sequence?

A

AAV
A virus which is very good at penetrating into tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the types of genetic disorders?

A

Monogenic/Mendelian
Polygenic/Complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the types of monogenic disorders?

A

Dominant
Recessive
X-linked
Mitochondrial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give an example of a monogenic disorder

A

Marfan’s syndrome
Retinitis Pigmentosa
Leber’s Congenital Amaurosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give an example of a polygenic disorder

A

Cataracts
Glaucoma
Refractive error

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is a polygenic disorder harder to ‘cure’ than a monogenic disorder?

A

Polygenic caused by multiple gene mutations, monogenic caused by one. Polygenic also affected by other environmental factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the difficulties of replacing non-functional genes?

A

Delivering gene to the correct tissue
Achieving the desired level of gene expression (generally only need a few %)
Preventing the vector from being degraded (needs to stay present, while not integrating into host cell DNA - so could be detected as virus)
Unwanted side effects (occur if vector integrates into host cell DNA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the types of dominant disorders?

A

Haploinsufficiency
Dominant-negative effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is haploinsufficiency?

A

50% functional protein is present, which is not enough for normal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can gene therapy help haploinsufficiency? What does it need to achieve to work?

A

Replacement of dysfunctional genes
Expression needs to be brought up to 100% for normal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the dominant-negative effect?

A

Abnormal protein has an adverse effect, preventing the function of the normal protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does gene therapy need to achieve to help the dominant-negative effect?

A

Block expression of abnormal protein but allow expression of normal protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is the abnormal protein blocked in treating the dominant negative effect?

A

Translation of dominant negative mRNA blocked by nucleic acid drugs which bind to the mutant mRNA and cleave it in two.
Delivered via ribozymes, antisense nucleic acids, siRNA or CRISPR-Cas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give an example of a haploinsufficiency

A

Stickler syndrome - vitreous malfunction which causes strands to be seen on slit lamp

17
Q

Give an example of the dominant-negative effect

A

Marfan’s syndrome - fibrillin gene mutation prevents triple helix formation so elastic fibres are not formed (e.g. if zonules of zinn dysfunctional, lens may dislocate)

18
Q

What are the difficulties of blocking the expression of an abnormal protein?

A

Achieving specificity for the mutant mRNA without degrading non-mutant mRNA
Delivering the gene to the correct tissue
Achieving desired level of gene expression
Preventing the delivery agent from being degraded

19
Q

How is CRISPR-Cas used for blood disorders?

A

Blood removed from px
CRISPR-Cas delivered to cell culture in lab (genes edited and cultured further)
Edited cells are returned to the px

20
Q

Why is the ability to edit genes outside of the body good?

A

Risk can be assessed before returning cells to the px
Less side effects
More controlled environment
Less clinic time for px and practitioner?

21
Q

What makes gene therapy difficult?

A

Mutation heterogeneity - mutation can occur anywhere on gene and usually varies between families
Non-mendelian diseases (polygenic) - difficult to correct multiple mutations
Ethics